Jos Jansen

1 Introduction to hepatic congenital glycosylation disorders 25 profiling by mass spectrometry for congenital disorders of glycosylation type II. Clinical chemistry. 2011;57(4):593-602. 57. van Scherpenzeel M, Steenbergen G, Morava E, Wevers RA, Lefeber DJ. High-resolution mass spectrometry glycoprofiling of intact transferrin for diagnosis and subtype identification in the congenital disorders of glycosylation. Translational research : the journal of laboratory and clinical medicine. 2015;166(6):639-49 e1. 58. Van Scherpenzeel M, Timal S, Rymen D, Hoischen A, Wuhrer M, Hipgrave-Ederveen A, et al. Diagnostic serum glycosylation profile in patients with intellectual disability as a result of MAN1B1 deficiency. Brain : a journal of neurology. 2014;137(Pt 4):1030-8. 59. Tegtmeyer LC, Rust S, van Scherpenzeel M, Ng BG, Losfeld ME, Timal S, et al. Multiple phenotypes in phosphoglucomutase 1 deficiency. The New England journal of medicine. 2014;370(6):533-42. 60. Duplomb L, Duvet S, Picot D, Jego G, El Chehadeh-Djebbar S, Marle N, et al. Cohen syndrome is associated with major glycosylation defects. Human molecular genetics. 2014;23(9):2391-9.